Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally.
Quote | Swedish Orphan Biovit Ord (OTCMKTS:BIOVF)
Last: | $22.87 |
---|---|
Change Percent: | 5.06% |
Open: | $23.735 |
Close: | $22.87 |
High: | $23.735 |
Low: | $22.87 |
Volume: | 3,000 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Swedish Orphan Biovit Ord (OTCMKTS:BIOVF)
2024-02-08 14:21:03 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2023 Results Conference Call February 08, 2024 08:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Lydia Abad-Franch - Head of R&a...
2024-02-08 06:11:24 ET More on Swedish Orphan Biovitrum AB Historical earnings data for Swedish Orphan Biovitrum AB Financial information for Swedish Orphan Biovitrum AB Read the full article on Seeking Alpha For further details see: Swedish Orphan Biovit...
Message Board Posts | Swedish Orphan Biovit Ord (OTCMKTS:BIOVF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...
Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023
As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Ab...